Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

Rotavirus vaccine efficacy up to 2 years of age and against diverse circulating rotavirus strains in Niger: Extended follow-up of a randomized controlled trial.

<h4>Background</h4>Rotavirus vaccination is recommended in all countries to reduce the burden of diarrhea-related morbidity and mortality in children. In resource-limited settings, rotavirus vaccination in the national immunization program has important cost implications, and evidence fo...

Full description

Bibliographic Details
Main Authors: Sheila Isanaka, Céline Langendorf, Monica Malone McNeal, Nicole Meyer, Brian Plikaytis, Souna Garba, Nathan Sayinzoga-Makombe, Issaka Soumana, Ousmane Guindo, Rockyiath Makarimi, Marie Francoise Scherrer, Eric Adehossi, Iza Ciglenecki, Rebecca F Grais
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-07-01
Series:PLoS Medicine
Online Access:https://doi.org/10.1371/journal.pmed.1003655

Internet

https://doi.org/10.1371/journal.pmed.1003655

Similar Items